CLINICAL TRIALS PROFILE FOR ZOLPIDEM TARTRATE
✉ Email this page to a colleague
All Clinical Trials for ZOLPIDEM TARTRATE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00044629 ↗ | Combined Behavioral/Pharmacological Therapy for Insomnia | Completed | National Institute of Mental Health (NIMH) | Phase 2 | 2001-09-01 | This study will determine how sleeping pills can be combined with nondrug treatments to maximize the benefits of therapy for insomnia. |
| NCT00044629 ↗ | Combined Behavioral/Pharmacological Therapy for Insomnia | Completed | Duke University | Phase 2 | 2001-09-01 | This study will determine how sleeping pills can be combined with nondrug treatments to maximize the benefits of therapy for insomnia. |
| NCT00084669 ↗ | Venlafaxine With or Without Zolpidem in Treating Hot Flashes and Associated Sleep Disorders in Women With Breast Cancer OR at High Risk for Developing Breast Cancer | Completed | Massachusetts General Hospital | N/A | 2004-05-01 | RATIONALE: Venlafaxine may be effective in relieving hot flashes caused by hormone therapy. Giving venlafaxine with zolpidem (a sleeping pill) may improve sleep and quality of life in women who are receiving hormone therapy for treatment or prevention of breast cancer. PURPOSE: This randomized clinical trial is studying giving venlafaxine together with zolpidem to see how well it works compared to venlafaxine alone in relieving hot flashes and associated sleep disorders in women who are receiving hormone therapy to treat or prevent breast cancer. |
| NCT00283790 ↗ | Residual Effects of Zolpidem Tartrate Extended Release and Eszopiclone Vs Placebo | Completed | Sanofi | Phase 4 | 2006-01-01 | Investigation of Psychomotor and Cognitive Residual Effects of Single Oral Doses of Zolpidem Tartrate Extended Release 12.5 mg and Eszopiclone 3 mg Compared to Placebo in Healthy Young Volunteers, Using Flurazepam 30 mg as an External Comparator |
| NCT00296179 ↗ | Ambien CR For Treatment Of Insomnia Associated With Depression When Used Concomitantly With Lexapro | Completed | Sanofi | Phase 4 | 2006-02-01 | To demonstrate overall improvement of insomnia in subjects treated with zolpidem tartrate extended-release (Ambien CR) and escitalopram (Lexapro) vs. subjects treated with placebo and escitalopram at 2 months. |
| NCT00296790 ↗ | Ambien CR vs. Placebo For Treatment Of Insomnia Associated With Anxiety When Used Concomitantly With Escitalopram (Lexapro) | Completed | Sanofi | Phase 4 | 2006-02-01 | A comparison of Zolpidem Tartrate Extended-Release (Ambien CR)vs. Placebo in the Treatment of Insomnia Associated with Generalized Anxiety Disorder (GAD) when Used Concomitantly with Escitalopram (Lexapro - antidepressant). |
| NCT00380081 ↗ | A Study of Zolpidem Tartrate Sublingual Tablet in Adult Patients With Insomnia | Completed | Transcept Pharmaceuticals | Phase 3 | 2006-04-01 | The purpose of this study is to evaluate sleep onset following administration of Transcept zolpidem tartrate sublingual tablet versus placebo in adult insomnia patients. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ZOLPIDEM TARTRATE
Condition Name
Clinical Trial Locations for ZOLPIDEM TARTRATE
Trials by Country
Clinical Trial Progress for ZOLPIDEM TARTRATE
Clinical Trial Phase
Clinical Trial Sponsors for ZOLPIDEM TARTRATE
Sponsor Name
